Litcius/Paper detail

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

Charlotte Hedin, Gina Sado, Nelson Ndegwa, Ellina Lytvyak, Andrew L. Mason, Aldo J. Montaño‐Loza, Alessio Gerussi, Francesca Saffioti, Douglas Thorburn, Emma Nilsson, Geir Larsson, Bjørn Moum, Kim N. van Munster, Cyriel Y. Ponsioen, Cynthia Levy, Nicholas Fonseca Nogueira, Christopher L. Bowlus, Neta Gotlieb, Oren Shibolet, Kate D. Lynch, Roger W. Chapman, Christian Rupp, Mette Vesterhus, Kristin Kaasen Jørgensen, Fredrik Rorsman, Christoph Schramm, João Sabino, Séverine Vermeire, Alessandra Zago, Nora Cazzagon, Hanns–Ulrich Marschall, Henriette Ytting, Karima Ben Belkacem, Olivier Chazouillères, Sven Almér, Annika Bergquist

2020Clinical Gastroenterology and Hepatology50 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdalimumabInterquartile rangeInfliximabPrimary sclerosing cholangitisInternal medicineGastroenterologyDiscontinuationCalprotectinUlcerative colitisTumor necrosis factor alphaInflammatory bowel diseaseRetrospective cohort studyDiseaseLiver Diseases and ImmunityPancreatitis Pathology and TreatmentGallbladder and Bile Duct Disorders